IMC Chicago’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
188,200
-14,000
-7% -$933K ﹤0.01% 1367
2026
Q1
$12.7M Sell
202,200
-166,400
-45% -$11.6M ﹤0.01% 1113
2025
Q4
$24.5M Buy
368,600
+102,900
+39% +$6.65M 0.01% 758
2025
Q3
$17.9M Buy
265,700
+40,300
+18% +$3.19M 0.01% 832
2025
Q2
$19.7M Sell
225,400
-65,800
-23% -$5.16M 0.01% 702
2025
Q1
$19.9M Sell
291,200
-122,900
-30% -$10M 0.01% 588
2024
Q4
$32.2M Buy
414,100
+85,300
+26% +$6.32M 0.02% 453
2024
Q3
$22M Buy
328,800
+114,600
+54% +$9.41M 0.01% 524
2024
Q2
$24.3M Buy
214,200
+48,700
+29% +$6.16M 0.01% 472
2024
Q1
$23M Sell
165,500
-20,800
-11% -$2.61M 0.01% 417
2023
Q4
$23.1M Buy
186,300
+42,200
+29% +$4.31M 0.02% 420
2023
Q3
$13.4M Buy
144,100
+87,600
+155% +$9.87M 0.01% 474
2023
Q2
$7.26M Buy
56,500
+4,800
+9% +$581K 0.01% 579
2023
Q1
$6.01M Buy
51,700
+24,200
+88% +$2.71M 0.01% 607
2022
Q4
$3.11M Buy
+27,500
New +$3.02M ﹤0.01% 715
2020
Q2
Sell
-111,600
Closed -$7.51M 909
2020
Q1
$7.51M Buy
+111,600
New +$6.94M 0.02% 250

Other funds holding DXCM

IMC Chicago's DXCM Position: Q2 2026 in Review

IMC Chicago sold out of DexCom (DXCM) in Q2 2026, closing a stake of 12,131 shares — an estimated $808K sold.

IMC Chicago first reported a position in DXCM in Q3 2023 and held it in 5 quarters. The position peaked at $3.68M in Q3 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • IMC Chicago reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 12,131 DexCom shares in Q2 2026, an estimated $808K.
  • IMC Chicago first reported a position in DexCom in Q3 2023 and held it in 5 quarters.
  • IMC Chicago's DexCom position peaked at $3.68M in Q3 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.